/Steris%20Plc%20logo%20and%20chart-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
STERIS stock has significantly underperformed the Nasdaq over the past 52 weeks, yet analysts remain strongly bullish on the stock’s prospects.
Despite STERIS’ underperformance relative to the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.
The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed unchanged, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.54%. Stocks on Thursday...
/Steris%20Plc%20site%20and%20phone-by%20T_Schneider%20via%20Shutterstock.jpg)
STERIS will release its second-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.
STERIS has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish about the stock’s potential.
STERIS has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s potential.
STERIS will unveil its Q1 earnings next month, and analysts project a single-digit bottom-line growth.